These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36156755)

  • 1. A Dancer with Fractures: What Lies Beneath?
    Habbsa S; Canakis A; George L; Thomas A; Hu Y; Cross RK; Whitlatch HB
    Dig Dis Sci; 2023 Jan; 68(1):54-57. PubMed ID: 36156755
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
    Ryhänen EM; Schalin-Jäntti C; Matikainen N
    Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced osteomalacia: a case report.
    Aligail K; Dave JA; Ross IL
    J Med Case Rep; 2022 Jan; 16(1):22. PubMed ID: 35016725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Fukumoto S; Yamashita T
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12892105
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Kida Y
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12890852
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer.
    Abramson M; Glezerman IG; Srinivasan M; Ross R; Flombaum C; Gutgarts V
    Clin Nephrol; 2021 Feb; 95(2):104-111. PubMed ID: 33191899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic osteomalacia--a complex dance of factors.
    Carpenter TO
    N Engl J Med; 2003 Apr; 348(17):1705-8. PubMed ID: 12711747
    [No Abstract]   [Full Text] [Related]  

  • 10. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.
    Leaf DE; Pereira RC; Bazari H; Jüppner H
    J Clin Endocrinol Metab; 2013 Mar; 98(3):887-91. PubMed ID: 23393166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burosumab in tumor-induced osteomalacia: A case report.
    Day AL; Gutiérrez OM; Guthrie BL; Saag KG
    Joint Bone Spine; 2020 Jan; 87(1):81-83. PubMed ID: 31382017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
    Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
    Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G; Varsavsky M
    Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.
    Rendina D; Abate V; Cacace G; D'Elia L; De Filippo G; Del Vecchio S; Galletti F; Cuocolo A; Strazzullo P
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3428-e3436. PubMed ID: 35468192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inability to walk in a 41-year-old man].
    Karaa-Zbidi N; Damade R; Lhote F
    Rev Med Interne; 2016 Jan; 37(1):62-5. PubMed ID: 26055036
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypophosphatemic osteomalacia].
    Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
    Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Hypophosphatemia due to Oncogenic Osteomalacia in a Patient with Natural Killer T-Cell Lymphoma.
    Zheng G; Kanduri SR; Canterbury JP; Nguyen T; Velez JCQ
    Kidney Blood Press Res; 2021; 46(5):647-651. PubMed ID: 34293749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.
    Tantisattamo E; Ng RC
    Hawaii Med J; 2011 Jul; 70(7):139-43. PubMed ID: 21886301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.